Novel antipsychotic medications in the treatment of children and adolescents.
Malone
R P
RP
Department of Psychiatry at MCP Hahnemann University School of Medicine in Philadelphia, Pennsylvania, USA. maloner@auhs.edu
Sheikh
R
R
Zito
J M
JM
D000293:Adolescent; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D002648:Child; D002665:Child Psychiatry / Q000639:trends*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D003024:Clozapine / Q000627:therapeutic use; D003987:Dibenzothiazepines / Q000627:therapeutic use; D006801:Humans; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives / Q000627:therapeutic use; D010818:Practice Patterns, Physicians' / Q000639:trends*; D000069348:Quetiapine Fumarate; D018967:Risperidone / Q000627:therapeutic use; D014481:United States
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D001569:Benzodiazepines; D000069348:Quetiapine Fumarate; D010890:Pirenzepine; D003024:Clozapine; D018967:Risperidone; D000077152:Olanzapine